Hosted by Aldevron and MaxCyte at the Leiden Biopark
Join us for an exclusive event hosted by Aldevron and MaxCyte, showcasing capabilities for cell and gene therapy development. Discover innovative solutions to accelerate your research and bring transformative therapies to life.
December 10, 2024
13.15-17.00
Kadans Meeting Room
Plus Ultra Leiden,
Leiden Bio Science Park,
Netherlands
Lunch will be provided. Space is limited, so we encourage you to reserve your spot today.
Presenters
- Alicia Roig-Merino, PhD
Senior Field Application Scientist, MaxCyte
Development of non-viral T-cell therapies; Complex gene editing in hard-to-transfect cells.
- Maarten Walmagh
Business Development Manager, Aldevron
Nanoplasmid™, the power of small; CRISPR-based therapeutics and streamlining the path to commercialisation.
